显微外科手术机器人市场机会、成长动力、产业趋势分析及2024年至2032年预测

Microsurgery Robot Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: 2024年11月11日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球显微外科机器人市场价值为13 亿美元，预计2024 年至2032 年将以13.9% 的复合年增长率强劲增长。。高风险手术对精确度的需求不断增加，促进了机器人系统的采用，因为它们可以提高准确性、改善手术结果并减少人为错误。

全球人口老化是推动市场成长的另一个重要因素。与年龄相关的疾病，如白内障、心血管疾病和关节炎，需要精细的手术介入。机器人显微手术系统提供更安全、微创的解决方案，确保患者更好的康復和满意度。

市场依应用分为不同类别，包括肿瘤学、心血管、神经血管、重建和眼科手术等。其中，肿瘤学领域在 2023 年引领市场，创造了 2.849 亿美元的收入。肿瘤学中的机器人系统提供无与伦比的精确度，使外科医生能够切除癌组织，同时保留周围的健康组织。这种能力对于确保干净的边缘和降低癌症復发的风险至关重要，特别是在敏感的解剖区域。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	13亿美元
预测值	42亿美元
复合年增长率	13.9%

就最终用途而言，市场分为医院和诊所、门诊手术中心、研究机构和其他设施。医院和诊所将在 2023 年成为主导领域，预计到 2032 年将达到 22 亿美元。学操作。随着医疗机构寻求现代化和保持竞争力，技术进步，包括将人工智慧和资料分析整合到机器人平台中，进一步增强了它们的价值。

2023 年，北美地区的收入为 7.375 亿美元，预计在预测期内复合年增长率为 13.2%。该地区的成长得益于人口老化、对微创解决方案不断增长的需求以及强大的私人医疗基础设施。私人医院和诊所对尖端技术的高额投资使北美成为采用显微手术机器人的领跑者。

产业生态系统分析
产业影响力
- 成长动力
  - 对微创外科手术的需求不断增加
  - 技术进步
  - 慢性病发生率上升
  - 已开发国家加大显微手术机器人研发资金投入
- 产业陷阱与挑战
  - 与机器人系统相关的高成本
  - 缺乏熟练的医疗保健专业人员
成长潜力分析
监管环境
报销场景
技术景观
波特的分析
PESTEL分析
启动场景
政策展望
未来市场趋势
差距分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
主要参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按应用划分，2021 - 2032 年

主要趋势
肿瘤手术
泌尿科
妇产科手术
显微吻合术
重建手术
耳鼻喉科手术
胃肠外科
心血管外科
输尿管肾镜检查
神经血管外科
眼科手术
其他应用

第 6 章：市场估计与预测：依最终用途，2021 - 2032 年

主要趋势
医院和诊所
门诊手术中心
科学研究机构
其他最终用户

第 7 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋

第 8 章：公司简介

Asensus Surgical
avateramedical
CMR Surgical
Distalmotion
Intuitive Surgical
Johnson & Johnson (Ethicon)
Medical Microinstruments
Medtronic
meerecompany
MicroSure
Siemens Healthineers
Smith & Nephew
Stryker Corporation
Titan Medical
Zimmer Biomet

简介目录

Product Code: 2814

The Global Microsurgery Robot Market was valued at USD 1.3 billion in 2023 and is projected to grow at a robust CAGR of 13.9% from 2024 to 2032. The market expansion is driven by the rising prevalence of chronic diseases, advancements in surgical technologies, a shortage of skilled surgeons, and favorable reimbursement policies. Increasing demand for precision in high-stakes surgeries boosts the adoption of robotic systems, as these offer enhanced accuracy, improved surgical outcomes, and reduced human error.

The aging global population is another significant factor fueling market growth. Age-related conditions, such as cataracts, cardiovascular diseases, and arthritis, require delicate surgical interventions. Robotic microsurgery systems provide safer, minimally invasive solutions, ensuring better patient recovery and satisfaction.

The market is segmented by application into various categories, including oncology, cardiovascular, neurovascular, reconstructive, and ophthalmology surgeries, among others. Among these, the oncology segment led the market in 2023, generating USD 284.9 million in revenue. Robotic systems in oncology offer unparalleled precision, enabling surgeons to remove cancerous tissues while preserving surrounding healthy tissues. This capability is critical in ensuring clean margins and reducing the risk of cancer recurrence, especially in sensitive anatomical regions.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$1.3 Billion
Forecast Value	$4.2 Billion
CAGR	13.9%

In terms of end-use, the market is divided into hospitals and clinics, ambulatory surgical centers, research institutes, and other facilities. Hospitals and clinics emerged as the dominant segment in 2023 and are projected to reach USD 2.2 billion by 2032. The adoption of robotic systems in hospitals is driven by their ability to enhance the accuracy and efficiency of complex procedures, such as cardiac, neurosurgical, and oncology operations. Technological advancements, including the integration of AI and data analytics into robotic platforms, are further augmenting their value as healthcare institutions seek to modernize and remain competitive.

North America accounted for USD 737.5 million in revenue in 2023 and is expected to grow at a CAGR of 13.2% during the forecast period. The region's growth is propelled by its aging population, increasing demand for minimally invasive solutions, and a strong private healthcare infrastructure. High investment in cutting-edge technologies by private hospitals and clinics has made North America a frontrunner in adopting microsurgery robots.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing demand for minimally invasive surgical procedures
  - 3.2.1.2 Technological advancements
  - 3.2.1.3 Rising incidences of chronic conditions
  - 3.2.1.4 Increasing funding for development of microsurgery robots in developed countries
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with robotic systems
  - 3.2.2.2 Dearth of skilled healthcare professionals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Start-up scenario
3.10 Policy outlook
3.11 Future market trends
3.12 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major key players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Oncology surgery
5.3 Urology surgery
5.4 Obstetrics and gynecology surgery
5.5 Micro anastomosis
5.6 Reconstructive surgery
5.7 ENT surgery
5.8 Gastrointestinal surgery
5.9 Cardiovascular surgery
5.10 Ureterorenoscopy
5.11 Neurovascular surgery
5.12 Ophthalmology surgery
5.13 Other applications

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospitals and clinics
6.3 Ambulatory surgical centers
6.4 Research institutes
6.5 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE